| Literature DB >> 35022445 |
Elizabeth Goult1,2, Shubha Sathyendranath3, Žarko Kovač4, Christina Eunjin Kong1, Petar Stipanović4, Anas Abdulaziz5, Nandini Menon6, Grinson George7, Trevor Platt1.
Abstract
In the absence of an effective vaccine or drug therapy, non-pharmaceutical interventions are the only option for control of the outbreak of the coronavirus disease 2019, a pandemic with global implications. Each of the over 200 countries affected has followed its own path in dealing with the crisis, making it difficult to evaluate the effectiveness of measures implemented, either individually, or collectively. In this paper we analyse the case of the south Indian state of Kerala, which received much attention in the international media for its actions in containing the spread of the disease in the early months of the pandemic, but later succumbed to a second wave. We use a model to study the trajectory of the disease in the state during the first four months of the outbreak. We then use the model for a retrospective analysis of measures taken to combat the spread of the disease, to evaluate their impact. Because of the differences in the trajectory of the outbreak in Kerala, we argue that it is a model worthy of a place in the discussion on how the world might best handle this and other, future, pandemics.Entities:
Mesh:
Year: 2022 PMID: 35022445 PMCID: PMC8755744 DOI: 10.1038/s41598-021-04488-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Kerala model structure. See Methods section for details.
Figure 2Observed and modelled COVID-19 cases in Kerala, from January 30th to May 30th 2020. (a) Modelled and reported active, hospitalised COVID-19 cases in the state. Also shown is the modelled total cases (in and out of hospital combined), shifted by 7 days, which is the number of days in the model between someone being suspected of having the disease and being officially reported. The minimum and maximum bounds of the modelled reported hospital cases from the MCMC fitting are included in grey. (b) Modelled and observed cumulative deaths due to COVID-19 in Kerala. Minimum and maximum bounds from the MCMC fitting are shown in grey.
Observations and model results.
| Model | Total cases | Reported cases | ||||
|---|---|---|---|---|---|---|
| Maximum (95% CI) | Cumulative (95% CI) | Maximum (95% CI) | Cumulative (95% CI) | Deaths (95% CI) | Mortality (%) (95% CI) | |
| (a) | ||||||
| Observed | – | – | 624 | 1208 | 9 | 0.75 |
| Reference model | 2084 (2068, 2100) | 3396 (3369, 3421) | 505 (501, 509) | 1116 (1107, 1124) | 8 (7, 8) | 0.670 (0.66, 0.69) |
| Reduced Testing | 12,617 (12,518, 12,716) | 20,417 (20,252, 20,582) | 2991 (2967, 3015) | 6561 (6505, 6616) | 45 (44, 45) | 0.68 (0.67, 0.69) |
| No travel restrictions | 21,019 (20,983, 21,056) | 30,104 (30,051, 30,157) | 5140 (5131, 5149) | 7439 (7425, 7453) | 50 (49, 50) | 0.67 (0.67, 0.67) |
| No out-of-hospital measures | 1,624,056 (1,609,944, 1,638,168) | 2,530,461 (2,508,033 , 2,552,889) | 590,961 (585,457, 596,464) | 856,110 (848,086, 864,134) | 5089 (5042, 5136) | 0.59 (0.58, 0.61) |
| No in-hospital quarantine | 17,709,110 (17,554,337, 17,863,884 ) | 33,300,000 (33,300,000, 33,300,000) | 17,540,530 (17,529,960, 17,551,340) | 31,056,110 (31,056,110, 31,056,110) | 208,699 (208,690, 208,708) | 0.67 (0.67, 0.67) |
| All measures removed | 17,516,461 (17,168,606, 17,864,315) | 33,300,000 (33,300,000, 33,300,000) | 17,353,330 (17,318,520, 17,388,140) | 31,056,220 (31,056,210, 31,056,220) | 208,283 (208,265, 208,301) | 0.67 (0.67, 0.67) |
| No track and trace | 16,226,350 (16,206,950, 16,245,980) | 28,408,000 (28,361,930, 28,454,070) | 11,195,940 (11,121,570, 11,270,310) | 14,211,250 (14,100,110, 14,322,400) | 71,264 (70,874,71,653) | 0.50 (0.49, 0.51) |
| No track and trace, no out-of-hospital measures | 15,342,950 (15,320,040, 15,366,590) | 32,874,741 (32,874,685, 32,874,797) | 15,235,970 (15,230,870, 15,241,060) | 30,645,140 (30,644,900, 30,645,380) | 196,482 (196,431, 196,534) | 0.64 (0.64, 0.64) |
| (b) | ||||||
| Country | Active | Cumulative | Deaths | Mortality (%) | ||
Canada (35.2 M) 26/01/2020 | 35,992 | 91,667 | 7158 | 7.8 | ||
Egypt (100 M) 14/02/2020 | 16,843 | 23,449 | 913 | 3.9 | ||
Germany (83 M) 27/01/2020 | 9751 | 183,189 | 8530 | 4.7 | ||
Italy (60 M) 31/01/2020 | 43,691 | 232,664 | 33,340 | 14.3 | ||
India (1380 M) 30/01/2020 | 89,706 | 181,827 | 5185 | 2.9 | ||
New Zealand (4.8 M) 28/02/2020 | 1 | 1504 | 22 | 1.5 | ||
(a) Observations and results from the reference model run, along with runs varying the level of state intervention. Mortality is calculated as the ratio of deaths to cumulative hospitalised cases. The maximum corresponds to the number of people modelled as being in hospital at the end of the study period. (b) Observations from other countries, and India including Kerala, for comparison. All snapshots are for 30th May, 2020, with the date of introduction given in the first column. The total population of each country is given in parentheses in the first column, in units of millions (M). Timeseries for these countries are shown in Fig. S3.
Figure 3Results from the exploration of government measures. (a) Compares the deaths due to COVID-19 in the state, and (b) compares the active COVID- 19 cases in Kerala. The number of hospital beds and ICU beds available in Kerala are also shown.